PTO- 2195 |
Approved for use through 12/31/2020. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Petition to Revive Abandoned Application - Failure to File Timely Statement of Use or Extension Request
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88569196 |
LAW OFFICE ASSIGNED |
LAW OFFICE 104 |
DATE OF NOTICE OF ABANDONMENT |
01/19/2021 |
MARK SECTION |
MARK FILE NAME |
http://uspto.report/TM/88569196/mark.png |
LITERAL ELEMENT |
BREYANZI |
STANDARD CHARACTERS |
NO |
USPTO-GENERATED IMAGE |
NO |
PETITION |
PETITION STATEMENT |
Applicant has firsthand knowledge that the failure to file an SOU or Extension Request by the specific deadline was unintentional, and requests
the USPTO to revive the abandoned application. |
NOTICE OF ALLOWANCE |
Notice of Allowance was received by applicant. |
EXTENSION OF TIME TO FILE STATEMENT OF USE |
OWNER SECTION (current) |
NAME |
JUNO THERAPEUTICS, INC. |
INTERNAL ADDRESS |
400 DEXTER AVENUENORTH |
MAILING ADDRESS |
SUITE 1200 |
CITY |
SEATTLE |
STATE |
Washington |
ZIP/POSTAL CODE |
98109 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
EMAIL |
XXXX |
OWNER SECTION (proposed) |
NAME |
JUNO THERAPEUTICS, INC. |
INTERNAL ADDRESS |
400 DEXTER AVENUENORTH |
MAILING ADDRESS |
SUITE 1200 |
CITY |
SEATTLE |
STATE |
Washington |
ZIP/POSTAL CODE |
98109 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
EMAIL |
XXXX |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma;
pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment
of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or
clinical use |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION PERIOD(S) |
2 |
ONGOING EFFORT |
product or service research or development |
ALLOWANCE MAIL DATE |
12/17/2019 |
CORRESPONDENCE INFORMATION (current) |
NAME |
Marilyn F. Kelly |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
uspto-tm@bms.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
maureen.manson@bms.com |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Marilyn F. Kelly |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
uspto-tm@bms.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
maureen.manson@bms.com |
DOCKET/REFERENCE NUMBER |
CELG1977US |
PAYMENT SECTION |
PETITION TO REVIVE (INCLUDING A PETITION TO DIRECTOR USED SOLELY AS A PETITION TO REVIVE) |
150 |
NUMBER OF CLASSES IN USE |
1 |
EXTENSION FEE |
125 |
TOTAL AMOUNT |
275 |
SIGNATURE SECTION |
PETITION SIGNATURE |
/Marilyn F. Kelly/ |
SIGNATORY'S NAME |
Xiomara Triana |
SIGNATORY'S POSITION |
Attorney of Record, NY Bar member |
DATE SIGNED |
01/21/2021 |
SIGNATURE METHOD |
Sent to third party for signature |
DECLARATION SIGNATURE |
/Marilyn F. Kelly/ |
SIGNATORY'S NAME |
Marilyn F. Kelly |
SIGNATORY'S POSITION |
Attorney of Record, NY Bar Member |
DATE SIGNED |
01/21/2021 |
SIGNATURE METHOD |
Sent to third party for signature |
FILING INFORMATION |
SUBMIT DATE |
Thu Jan 21 14:45:21 ET 2021 |
TEAS STAMP |
USPTO/PSE-XX.XXX.XX.XXX-2
0210121144521054808-88569
196-760f18b658368ce434a77
6d8a7f5c911911567dcd28eaf
fc84fe78ae25084ae3159-DA-
45196670-2021012114191728
6310 |
PTO- 2195 |
Approved for use through 12/31/2020. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Petition to Revive Abandoned Application - Failure to File Timely Statement of Use or Extension Request
To the Commissioner for Trademarks:
MARK: BREYANZI (Stylized and/or with Design, see
mark )
SERIAL NUMBER: 88569196
PETITION Petition Statement
Signatory has firsthand knowledge that the failure to file an SOU or Extension Request by the specific deadline was unintentional, and requests the USPTO to revive the abandoned application. Notice
of Allowance was received by applicant.
EXTENSION OF TIME TO FILE STATEMENT OF USE
The owner proposes to amend the following:
Current: JUNO THERAPEUTICS, INC., having an address of
400 DEXTER AVENUENORTH
SUITE 1200
SEATTLE, Washington 98109
United States
Email: XXXX
Proposed: JUNO THERAPEUTICS, INC., having an address of
400 DEXTER AVENUENORTH
SUITE 1200
SEATTLE, Washington 98109
United States
Email: XXXX
requests revival of the application identified above, and submits extension(s) of time to file the Statement of Use under 37 C.F.R. Section 2.89. The Notice of Allowance mailing date was
12/17/2019.
The applicant is filing extension number(s): 2
The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or
development
For International Class 005:
Current identification: Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations for
inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and
biological preparations for immunotherapy, including T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use
The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently
modified for this specific class.
Correspondence Information (current):
Marilyn F. Kelly
PRIMARY EMAIL FOR CORRESPONDENCE: uspto-tm@bms.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): maureen.manson@bms.com
Correspondence Information (proposed):
Marilyn F. Kelly
PRIMARY EMAIL FOR CORRESPONDENCE: uspto-tm@bms.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): maureen.manson@bms.com
The docket/reference number is CELG1977US.
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $150 will be submitted with the form, representing payment for the petition to revive fee.
A fee payment in the amount of $125 will be submitted with the form, representing payment for the extension fee.
A fee payment in the total amount of $275 will be submitted.
Petition
Signature: /Marilyn F. Kelly/ Date Signed: 01/21/2021
Signatory's Name: Xiomara Triana
Signatory's Position: Attorney of Record, NY Bar member
Declaration
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and that all
statements made on information and belief are believed to be true.
STATEMENTS FOR PETITION TO REVIVE: The signatory believes that he/she has firsthand knowledge that the applicant's failure to timely file a statement of use (SOU) or request for an extension of time
to file a statement of use (extension request) was unintentional; and requests that the USPTO revive the application.
STATEMENTS FOR SOU: The signatory believes that: if the applicant is filing the SOU under 15 U.S.C. §1051(d), the applicant is the owner of the mark sought to be registered;
for a trademark or
service mark application, the applicant is using the mark in commerce on or in connection with all the goods/services in the notice of allowance or as subsequently modified;
for a
collective trademark, collective service mark, or collective membership mark application, the applicant is exercising legitimate control over the use of the mark in commerce by members on or
in connection with the goods/services/collective membership organization in the notice of allowance or as subsequently modified;
for a certification mark application, the applicant is
exercising legitimate control over the use of the mark in commerce by authorized users on or in connection with the goods/services in the notice of allowance or as subsequently modified and the
applicant is not engaged in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the
goods/services that meet the certification standards of the applicant; that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, authorized users, members,
and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the
goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive; and the specimen(s) shows the mark as used on or in connection with the
goods/services/collective membership organization in commerce.
STATEMENTS FOR EXTENSION REQUEST: The signatory believes that: if the applicant is filing the extension request under 15 U.S.C. §1051(d),
for a trademark or service mark application,
the applicant has a continued bona fide intention to use the mark in commerce on or in connection with all the goods/services under §1(b) in the notice of allowance or as subsequently modified;
for a collective trademark, collective service mark, or collective membership mark application, the applicant has a bona fide intention to exercise legitimate control over the use of
the mark in commerce by members on or in connection with the goods/services/collective membership organization in the notice of allowance or as subsequently modified;
for a certification mark
application, the applicant has a bona fide intention to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the goods/services in the
notice of allowance or as subsequently modified and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote
recognition of the certification program or of the goods/services that meet the certification standards of the applicant; and that to the best of the signatory's knowledge and belief, no other
persons, except, if applicable, authorized users, members, and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be
likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
Signature: /Marilyn F. Kelly/ Date Signed: 01/21/2021
Signatory's Name: Marilyn F. Kelly
Signatory's Position: Attorney of Record, NY Bar Member
Signature method: Sent to third party for signature
Serial Number: 88569196
Internet Transmission Date: Thu Jan 21 14:45:21 ET 2021
TEAS Stamp: USPTO/PSE-XX.XXX.XX.XXX-2021012114452105
4808-88569196-760f18b658368ce434a776d8a7
f5c911911567dcd28eaffc84fe78ae25084ae315
9-DA-45196670-20210121141917286310